An In Silico Strategy against Adam’s Oliver Syndrome by Predicting RNAi Molecules against Dominant Genes by Suppressing Rho GTPases.
Asian Journal of Pharmaceutics (AJP),
[S. l.], v. 16, n. 3, 2022. DOI:
10.22377/ajp.v16i3.4483. DisponÃvel em:
https://www.asiapharmaceutics.info/index.php/ajp/article/view/4483. Acesso em: 14 apr. 2026.